News & Events

The University of Pittsburgh School of Medicine has identified a new molecular pathway in the liver that suggests a commonly used anti-rejection medication could be

Stroke therapies currently available, like clot busting drugs or clot removal devices, are focused on limiting the extent of brain damage. Now, research from the